5 May 2022 - Patient reported outcomes are increasingly collected in clinical trials and in routine clinical practice, but strategies ...
2 March 2022 - The final Phase 3 clinical data for CanSino Biologics' adenovirus type 5 vector vaccine show that Ad5-nCoV ...
1 February 2022 - In draft guidance published on 5 January 2022, NICE announced their decision not to recommend the use ...
8 December 2021 - PHARMAC has been accused of institutional racism and breaching the Treaty of Waitangi for funding drugs ...
10 November 2021 - Many researchers working on health technology assessments are keen to address disparities in health care. ...
24 September 2021 - The World Health Organization welcomes the addition of another therapeutic to the world’s arsenal against COVID-19, ...
19 August 2021 - The Africa director at the World Health Organization, Dr. Matshidiso Moeti, criticized the decisions by some ...
2 July 2021 - The controversial approval last month by the FDA of Aduhelm (aducanumab) for patients with early-stage Alzheimer’s disease ...
7 February 2021 - The UK’s NICE recently launched a consultation on the methods it uses to evaluate new health technologies, ...
29 January 2021 - Over the past 2 weeks numerous US states have announced a major shift in coronavirus disease ...
16 December 2020 - I have been asked many times: Does the vision of the CEO have the power to ...
3 November 2020 - PHARMAC is pleased to announce the launch of He Ako Hiringa, a clinical education provider with ...
21 October 2020 - Access to the latest and most effective drugs for Australians with diabetes can depend on where ...
20 October 2020 - Plan now for decisions on which vaccines should go to whom, when and how often. ...
6 October 2020 - Gavi, the Vaccine Alliance has welcomed pledges made this week in support of the Gavi COVAX AMC, ...